InvestorsHub Logo
Followers 69
Posts 7614
Boards Moderated 0
Alias Born 01/10/2014

Re: Anshu2 post# 384346

Monday, 11/21/2022 9:28:01 AM

Monday, November 21, 2022 9:28:01 AM

Post# of 463446
Accelerated Approval and surrogate/biological biomarkers is actually part of the plan if one has been paying attention to Anavex's analytical partner Ariana Pharma presentations.

https://www.arianapharma.com/

Point: Either AVXL's ad drug would be approval or not. There is nothing like approval conditioned on an additional trial (except for AA, which is very likely not applicable here).



surrogate/biological biomarkers are ABSOLUTELY applicable to Anavex and potential Accelerated Approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News